Ignite Creation Date:
2024-05-06 @ 1:25 AM
Last Modification Date:
2024-10-26 @ 11:03 AM
Study NCT ID:
NCT01801111
Status:
COMPLETED
Last Update Posted:
2018-11-02
First Post:
2013-02-20
Brief Title:
A Study of Alectinib RO5424802 in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase ALK Mutation and Failed Crizotinib Treatment
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-20
First Submit QC Date:
February 26 2013
Study First Post Date:
2013-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-05-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-31
Last Update Post Date:
2018-11-02
Last Update Post Date Type:
ACTUAL